And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest — so far at least. We plan to check in on the Pharmalot ancestors, hang with our short person, and promenade with the official mascots. And what about you? Now that spring is really here, this may be a good time to tidy up around the castle or manicure the grounds. If you feel adventurous, you can take a long drive and enjoy the great outdoors. Or maybe you want to place a bet on whether another Saturday Night Massacre occurs in Washington. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Four of the 20 biggest health-care companies in the S&P 500 Index saw a benefit from the tax overhaul in the fourth quarter, Bloomberg News says. The biggest gain was registered by Pfizer (PFE) with a $11.5 billion benefit. The difference lies in how companies decided to deal with overseas cash. Most companies that saw a tax charge in the quarter did not consider overseas earnings permanently reinvested and paid a repatriation transition tax. These companies elected to pay off their tax charges over the next eight years.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy